Breast Cancer Episode 32: Imlunestrant with or without abemaciclib for patients with ER+/HER2- metastatic breast cancer who progressed on endocrine therapy: EMBER-3 wondermedia 15 May 2025
Breast Cancer Episode 31: Adjuvant olaparib for BRCA-mutated early-stage breast cancer: long-term results of the OlympiA trial wondermedia 24 April 2025
Breast Cancer Episode 30: Radiation therapy offers better quality of life than adjuvant endocrine therapy in elderly patients with HR+/HER2- early breast cancer: the EUROPA trial wondermedia 2 April 2025
Breast Cancer Episode 29: Palbociclib delays disease progression in patients with HER2+/HR+ advanced breast cancer: results of the PATINA trial wondermedia 20 March 2025
Breast Cancer Episode 28: Omitting a sentinel lymph node biopsy in selected patients with early stage breast cancer undergoing breast conserving surgery: the INSEMA study wondermedia 6 March 2025
Breast Cancer Episode 27: Perioperative atezolizumab does not improve event-free survival in early-stage triple negative breast cancer: results of the phase III GeparDouze trial wondermedia 19 February 2025
Breast Cancer Episode 26: Perioperative pembrolizumab for early stage triple negative breast cancer: overall survival and biomarker analyses of KEYNOTE-522 Admin 6 February 2025
Breast Cancer Episode 25: Elacestrant for CDK4/6 inhibitor pretreated patients with HR+/HER2- advanced breast cancer: real-world data and updated results from the EMERALD trial wondermedia 22 January 2025
Breast Cancer Episode 24: Olaparib as a treatment option in germline BRCA-mutated, HER2- metastatic breast cancer: the OlympiAD trial 2 May 2024
Breast Cancer Episode 23: ESMO clinical practice guidelines for early-stage breast cancer 25 April 2024
